8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Myeloid Leukemia · Recurrent Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • City of Hope Medical Center, Duarte, California, United States

    Contact: Study coordinator (Vinod Pullarkat) · vpullarkat@coh.org · 626-359-8111
    Contact: Principal Investigator (Vinod Pullarkat)
Study leads
  • Vinod Pullarkat

    Principal Investigator

    City of Hope Medical Center